Dr. Rosh Sethi is a head and neck surgeon at Brigham and Women's Hospital and the Dana-Farber Cancer Institute. Dr. Sethi graduated from Yale University with a degree in molecular, cellular and developmental biology. He subsequently earned his medical degree from Harvard Medical School and his MPH in quantitative methods from the Harvard T.H. Chan School of Public Health. He completed his residency training at the Harvard Combined Residency Program in Otolaryngology–Head and Neck Surgery and his fellowship training in head and neck surgical oncology and microvascular reconstructive surgery at the University of Michigan.

Dr. Sethi is a member of the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. As part of the Dana-Farber Head and Neck Cancer Treatment Center, Dr. Sethi works within a multidisciplinary team to provide comprehensive and patient-centered cancer care. He specializes in the treatment of head and neck cancers including oral cavity and oropharynx tumors, larynx (voice box) tumors, thyroid and parathyroid tumors, salivary gland tumors, cutaneous tumors and sinonasal tumors. He is trained in advanced microvascular reconstruction of the head and neck and transoral robotic surgery.

Dr. Sethi's research interests include innovations of head and neck cancer treatment, health outcomes around oncologic care and cost-reduction measures for patients undergoing treatment for head and neck cancer.